The generic availability of Savella (milnacipran hydrochloride) is a key consideration for patients and healthcare providers. While specific dates can vary due to patent expirations and regulatory approvals, the landscape for generic Savella is evolving.
When will generic Savella be available?
The availability of generic versions of prescription drugs like Savella typically follows the expiration of their patents. Information regarding the precise patent expiration dates for Savella and any subsequent patent challenges is crucial for determining when generic competition can emerge. DrugPatentWatch.com provides detailed information on pharmaceutical patents, which can help track these timelines [1].
What are the potential benefits of generic Savella?
Generic drugs are bioequivalent to their brand-name counterparts, meaning they have the same active ingredient, dosage form, strength, and route of administration. The primary benefit of generic availability is usually a significant reduction in cost, making treatment more affordable for patients.
What is Savella used to treat?
Savella is a serotonin and norepinephrine reuptake inhibitor (SNRI) approved for the management of fibromyalgia in adults [2]. Fibromyalgia is a chronic condition characterized by widespread musculoskeletal pain accompanied by fatigue, sleep, memory, and mood issues.
How does Savella work?
As an SNRI, Savella is believed to work by increasing the levels of serotonin and norepinephrine in the brain. These neurotransmitters play a role in modulating pain signals, and their increased availability may help reduce the perception of pain associated with fibromyalgia [2].
What are the alternatives to Savella?
Treatment for fibromyalgia often involves a multi-faceted approach. Other medications that may be prescribed include other SNRIs, selective serotonin reuptake inhibitors (SSRIs), certain anticonvulsants (like gabapentin and pregabalin), and muscle relaxants. Non-pharmacological treatments such as exercise, cognitive behavioral therapy, and stress management are also important components of care [3].
What are the common side effects of Savella?
Commonly reported side effects of Savella include nausea, headache, constipation, dry mouth, vomiting, diarrhea, insomnia, and increased sweating [2]. Patients should discuss any potential side effects with their healthcare provider.
What are the risks associated with Savella?
Savella carries a boxed warning regarding the risk of suicidal thoughts and behaviors in children, adolescents, and young adults [2]. Patients taking Savella should be monitored for any changes in mood or behavior. Other potential risks include an increased risk of bleeding, activation of mania/hypomania in bipolar patients, and withdrawal symptoms if stopped abruptly [2].
Who manufactures Savella?
Savella is manufactured by AbbVie [4]. Understanding the original manufacturer is often a starting point for research into the drug's history and patent landscape.
Sources:
[1] https://drugpatentwatch.com/
[2] Savella prescribing information
[3] Mayo Clinic - Fibromyalgia
[4] Drugs.com - Savella